| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.940061 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240823145414 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 240702t20242024onca o f000 0 eng d |
|---|
| 020 | |a9780660726007 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-375/2024E-PDF |
|---|
| 245 | 00|aGovernment of Canada's health products post-market surveillance cycle. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c[2024] |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (2 unnumbered pages) : |bcolour illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Cycle de surveillance après la mise en marché du Gouvernement du Canada. |
|---|
| 500 | |a"Pub.: 240325." |
|---|
| 650 | 0|aHealth products|xSafety measures|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tCycle de surveillance après la mise en marché du Gouvernement du Canada.|w(CaOODSP)9.940060 |
|---|
| 856 | 40|qPDF|s542 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-375-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting/health-products-post-market-surveillance-cycle.html |
|---|